resources

Nephrocare Health Services Ltd.

NSE: NEPHROPLUS

BSE: 544647

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

617.15-3.8 (-0.61%)

14 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Nephrocare Health Services Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2026
Annual Reports	FY 2026
Quarterly Results	Jun
Conference Calls	18Feb 27May 19Aug
Presentations	10Feb 19May 11Aug

Corporate Announcements and Regulatory Filings

Nephrocare Health Services Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Board Meeting12 Oct 2026
Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.
Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30th September, 2026 received from M/s. KFIN Technologies Limited.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201128 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polar Capital Funds PLC
Closure of Trading Window25 Sept 2026
Closure of Trading Window
Trading window shall be closed till 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter and half yearly ended September 30, 2026.
Analyst / Investor Meet22 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
Credit Rating18 Sept 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform the update on Credit Ratings of the Company received from India Ratings and Research Private Limited as per the disclosure ....
Restructuring18 Sept 2026
Announcement under Regulation 30 (LODR)-Restructuring
Disclosure under Reg 30 of SEBI Listing Regulations -Rationalisation and Consolidation of Company''s Step-down Subsidiaries in the Philippines as per the disclosure annexed herewith.
Memorandum of Understanding /Agreements14 Sept 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform you that Nephrocare Health Services, Philippines Inc., a step-down wholly owned subsidiary of the Company has acquired a ....
General3 Sept 2026
Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.
We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.
Acquisition1 Sept 2026
Announcement under Regulation 30 (LODR)-Acquisition
Pursuant to Reg 30 of SEBI Listing Regulations, we wish to hereby inform that NephroPlus Health Services Kazakhstan LLP, an overseas subsidiary of the Company has entered into a Share Purchase ....
General31 Aug 2026
Disclosure Under Regulation 30 Of SEBI Listing Regulations
Pursuant to Regulation 30 of SEBI Listing Regulations, we hereby inform that the Company has received Tax demand pursuant to Tax Audit as per the annexed disclosure.
Memorandum of Understanding /Agreements17 Aug 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform that Nephrocare Health Services, Phillipines Inc., a step-down wholly-owned subsidiary of the Company has acquired a dialysis ....
AGM13 Aug 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declartion of voting results along with scrutinizers report of the 17th AGM of the Company.
Analyst / Investor Meet13 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
Memorandum of Understanding /Agreements13 Aug 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform that Nephrocare Health Services, Phillipines Inc., an overseas stepdown wholly-owned subsidiary of the Company has acquired ....
Acquisition12 Aug 2026
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Clarification to disclosure under Reg 30 dated May 26, 2026 regarding incorporation of Nephrocare Services Kazakhstan LLP.
AGM12 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 17th AGM of the Company.
Analyst / Investor Meet12 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In Continuation to our letter dated July 24, 2026 please find enclosed link of the audio recording of the Investors'' Conference Call held on August 12, 2026 on the Unaudited Standalone ....
Monitoring Agency Report11 Aug 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to Reg 32 of SEBI Listing Regulations, read with Reg 41 of SEBI ICDR Regulations, please find enclosed herewith Monitoring Agency Report for quarter ended June 30, 2026.
Outcome without intimation11 Aug 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On August 11, 2026.
Please find attached the outcome of Board meeting held on August 11, 2026.

Frequently Asked Questions

Where can I download the annual report of Nephrocare Health Services Ltd.?

Annual reports of Nephrocare Health Services Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Nephrocare Health Services Ltd.?

Quarterly earnings results and presentations of Nephrocare Health Services Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Nephrocare Health Services Ltd. publish earnings call transcripts?

Earnings call transcripts of Nephrocare Health Services Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Nephrocare Health Services Ltd.?

Investor presentations and annual day presentations of Nephrocare Health Services Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Nephrocare Health Services Ltd.?

Corporate announcements and regulatory filings of Nephrocare Health Services Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Nephrocare Health Services Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Nephrocare Health Services Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Nephrocare Health Services Ltd.?

The ISIN (International Securities Identification Number) of Nephrocare Health Services Ltd. is INE428V01029. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Nephrocare Health Services Ltd. listed?

Nephrocare Health Services Ltd. is listed on NSE and BSE. The NSE symbol is NEPHROPLUS and the BSE code is -.

Where can I find the shareholding pattern of Nephrocare Health Services Ltd.?

The quarterly shareholding pattern of Nephrocare Health Services Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Nephrocare Health Services Ltd. on Sharpely?

Share price data for Nephrocare Health Services Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.